Experimental use exception
Also called experimental use defense, experimental use exemption, patent research exception
Experimental use exception refers in US patent law to the narrow common-law defense to Patent infringement described by the Federal Circuit in Madey v. Duke University (2002) for acts done solely for amusement, to satisfy idle curiosity, or for strictly philosophical inquiry1.
Article 27(b) of the Unified Patent Court Agreement separately limits patent rights for acts done for experimental purposes relating to the subject matter of the patented invention2.
US common law under Madey
In Madey (2002), the US Court of Appeals for the Federal Circuit said that, regardless of whether the institution or entity pursues commercial gain, an act that furthers the alleged infringer's legitimate business and is not solely for amusement, to satisfy idle curiosity, or for strictly philosophical inquiry does not qualify1.
In Madey (2002), the Federal Circuit said the user's for-profit or nonprofit status is not determinative1.
The separate rule under the Unified Patent Court Agreement
Article 27(b) provides that the rights conferred by a patent do not extend to acts done for experimental purposes relating to the subject matter of the patented invention2.
US common-law defense versus regulatory safe harbor
| US rule | What it turns on |
|---|---|
| Common-law experimental use | The Federal Circuit in Madey (2002) focused on the alleged infringer's legitimate business and on whether the use was solely for amusement, idle curiosity, or strictly philosophical inquiry1. |
| Section 271(e)(1) | The statutory Bolar safe harbor in section 271(e)(1) exempts making, using, offering to sell, or selling a patented invention in the United States, or importing it into the United States, solely for uses reasonably related to developing and submitting information under federal law regulating the manufacture, use, or sale of drugs or veterinary biological products3. The exemption excludes a new animal drug or veterinary biological product, as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Act of March 4, 1913, if it is manufactured primarily using recombinant DNA, recombinant RNA, hybridoma technology, or another process involving site-specific genetic manipulation3. |
Questions people ask
Check a product
FTO Search AI Agent
Turn product details into a reviewable search strategy, focused patent candidates, and evidence your IP team can take further.
Run FTO SearchDoes US nonprofit status establish the experimental use defense?
No, the Federal Circuit in Madey (2002) said that nonprofit status is not determinative and directed attention to the alleged infringer's legitimate business and whether the use was solely for amusement, to satisfy idle curiosity, or for strictly philosophical inquiry1.
Does Article 27(b) apply to every use in an experiment?
No, Article 27(b) limits the exception to acts done for experimental purposes relating to the subject matter of the patented invention2.
Is the US common-law defense the same as the Bolar exemption?
No. The Federal Circuit in Madey (2002) addressed the US common-law experimental use defense1. Section 271(e)(1) provides the separate statutory Bolar safe harbor for acts that meet its conditions3.
How it connects
Go from the term to the task
Read how the method works, run it on your own product or idea, then try a free tool.
- 01 / How-toHow to run a freedom-to-operate analysisScope, search, claim review and the report counsel will ask for.Read
- 02 / AI agentFTO Search AI AgentTurn product details into a reviewable search strategy, focused patent candidates, and evidence your IP team can take further.Run it